Factor | Coefficient b | 95% CI | p |
---|---|---|---|
Observation and control groups | Â | Â | Â |
Groups from observational studies (reference group) | −2 · 26 | −2 · 56 - -1 · 96 | <0 · 001 |
Non-antibiotic methods; | Â | Â | Â |
• Gastric study control | −0 · 28 | −0 · 82 - +0 · 26 | 0 · 31 |
• Airway study control | −0 · 11 | −0 · 72 - +0 · 49 | 0 · 71 |
SDD control groups; | Â | Â | Â |
• Non-concurrent control | +0 · 43 | −0 · 12 - +0 · 98 | 0 · 12 |
• RCCT controlc | +0 · 90 | +0 · 52 - +1 · 28 | <0 · 001 |
• Control group receiving PPAPd | −0 · 94 | −1 · 54 - -0 · 34 | 0 · 002 |
CDC bacteremia criteria | −0 · 24 | −0 · 54 - +0 · 07 | 0 · 13 |
Observation and intervention groups | Â | Â | Â |
Groups from observational studies (reference group) | −2 · 35 | −2 · 64 - -2 · 07 | <0 · 001 |
Non-antibiotic methods; | Â | Â | Â |
• Gastric study intervention | −0 · 32 | −0 · 84 - +0 · 21 | 0 · 23 |
• Airway study intervention | −0 · 39 | −0 · 97 - +0 · 18 | 0 · 18 |
SDD intervention groups; | Â | Â | Â |
• Non-concurrent and topical intervention alonee | +0 · 48 | −0 · 12 - +1 · 08 | 0 · 12 |
• RCCT and topical intervention alone | +0 · 97 | +0 · 50 - +1 · 44 | <0 · 001 |
• Intervention group receiving PPAPd | −0 · 77 | −1 · 24 - -0 · 29 | 0 · 002 |
CDC bacteremia criteria | −0 · 09 | −0 · 38 - +0 · 21 | 0 · 56 |